According to our (Global Info Research) latest study, the global Umbilical Cord Blood and Tissue Storage Service market size was valued at US$ 17239 million in 2025 and is forecast to a readjusted size of US$ 33272 million by 2032 with a CAGR of 10.0% during review period.
Umbilical cord blood and tissue storage refers to the aseptic collection of umbilical cord blood and tissue after birth, followed by testing, separation, cell processing, and cryopreservation in liquid nitrogen for long-term storage of the rich hematopoietic stem cells, mesenchymal stem cells, and other cell resources with regenerative medicine value. Umbilical cord blood primarily contains hematopoietic stem cells, which can be used to treat diseases such as leukemia, lymphoma, aplastic anemia, and thalassemia. Umbilical cord tissue is rich in mesenchymal stem cells, with broad application potential in tissue repair, immune regulation, and regenerative medicine. Storage models include public banks, private banks, and hybrid models, serving families, hospitals, research institutions, and cell therapy companies, and is an important component of the cell therapy and precision medicine industry.
With the development of stem cell therapy, regenerative medicine, gene therapy, and precision medicine, the umbilical cord blood and tissue storage industry is gradually transforming from traditional "bioinsurance" to a cell resource platform and regenerative medicine infrastructure. Currently, umbilical cord blood is used to treat more than 80 diseases, and clinical research on mesenchymal stem cells derived from umbilical cord tissue continues to increase in the fields of neurodegenerative diseases, diabetes, autoimmune diseases, cardiovascular repair, and tissue engineering. With the development of CAR-T therapy, induced pluripotent stem cell (iPSC) therapy, exosome therapy, and personalized medicine, the demand for umbilical cord tissue storage is expected to grow faster than that for traditional cord blood storage. The Asia-Pacific region, particularly China, India, and Southeast Asia, will be the fastest-growing market, while the construction of public banks, long-term storage services, and the commercialization of cell therapy will drive the industry's continued expansion.
This report is a detailed and comprehensive analysis for global Umbilical Cord Blood and Tissue Storage Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Umbilical Cord Blood and Tissue Storage Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Umbilical Cord Blood and Tissue Storage Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Umbilical Cord Blood and Tissue Storage Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Umbilical Cord Blood and Tissue Storage Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Umbilical Cord Blood and Tissue Storage Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Umbilical Cord Blood and Tissue Storage Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cord Blood Registry, Cryo-Cell, ViaCord, Americord Registry, Cord For Life, MiracleCord, Stemcyte, Cenbest, Famicord Group, Anja Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Umbilical Cord Blood and Tissue Storage Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Private Banks
Public Banks
Mixed Banks
Market segment by Operating Models
Umbilical Cord Blood Storage
Umbilical Cord Tissue Storage
Placement Tissue Storage
Amnion Tissue Storage
Multi-Tissue Combined Storage
Market segment by Cell Types
Hematopoietic Stem Cells
Mesenchymal Stem Cells
Endothelial Progenitor Cells
Others
Market segment by Application
Blood Diseases
Immune Diseases
Nervous System Diseases
Genetic Metabolic Diseases
Congenital Diseases
Others
Market segment by players, this report covers
Cord Blood Registry
Cryo-Cell
ViaCord
Americord Registry
Cord For Life
MiracleCord
Stemcyte
Cenbest
Famicord Group
Anja Health
Smart Cells
Cells4Life
Chinacord
Landfarbio Group
Yuanpin Bio
Qilu Cellbank
Cordlife
StemCell Institute
MEDIPOST
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Umbilical Cord Blood and Tissue Storage Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Umbilical Cord Blood and Tissue Storage Service, with revenue, gross margin, and global market share of Umbilical Cord Blood and Tissue Storage Service from 2021 to 2026.
Chapter 3, the Umbilical Cord Blood and Tissue Storage Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Umbilical Cord Blood and Tissue Storage Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Umbilical Cord Blood and Tissue Storage Service.
Chapter 13, to describe Umbilical Cord Blood and Tissue Storage Service research findings and conclusion.
Summary:
Get latest Market Research Reports on Umbilical Cord Blood and Tissue Storage Service. Industry analysis & Market Report on Umbilical Cord Blood and Tissue Storage Service is a syndicated market report, published as Global Umbilical Cord Blood and Tissue Storage Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Umbilical Cord Blood and Tissue Storage Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.